Thermo Fisher Scientific Inc (TMO)
567.98
+5.22
(+0.93%)
USD |
NYSE |
May 31, 16:00
568.53
+0.55
(+0.10%)
Pre-Market: 20:00
Thermo Fisher Scientific Free Cash Flow: 7.56B for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 7.56B |
| December 31, 2023 | 6.927B |
| September 30, 2023 | 6.546B |
| June 30, 2023 | 5.854B |
| March 31, 2023 | 5.62B |
| December 31, 2022 | 6.911B |
| September 30, 2022 | 5.60B |
| June 30, 2022 | 6.336B |
| March 31, 2022 | 7.001B |
| December 31, 2021 | 6.789B |
| September 30, 2021 | 7.916B |
| June 30, 2021 | 8.132B |
| March 31, 2021 | 8.062B |
| December 31, 2020 | 6.815B |
| September 30, 2020 | 5.686B |
| June 30, 2020 | 4.245B |
| March 31, 2020 | 3.702B |
| December 31, 2019 | 4.047B |
| September 30, 2019 | 3.94B |
| June 30, 2019 | 4.086B |
| March 31, 2019 | 4.273B |
| December 31, 2018 | 3.785B |
| September 30, 2018 | 3.919B |
| June 30, 2018 | 3.689B |
| March 31, 2018 | 3.189B |
| Date | Value |
|---|---|
| December 31, 2017 | 3.497B |
| September 30, 2017 | 2.918B |
| June 30, 2017 | 2.825B |
| March 31, 2017 | 2.862B |
| December 31, 2016 | 2.814B |
| September 30, 2016 | 2.966B |
| June 30, 2016 | 2.885B |
| March 31, 2016 | 2.756B |
| December 31, 2015 | 2.519B |
| September 30, 2015 | 2.092B |
| June 30, 2015 | 2.035B |
| March 31, 2015 | 2.178B |
| December 31, 2014 | 2.192B |
| September 30, 2014 | 2.029B |
| June 30, 2014 | 1.893B |
| March 31, 2014 | 1.492B |
| December 31, 2013 | 1.728B |
| September 30, 2013 | 1.65B |
| June 30, 2013 | 1.605B |
| March 31, 2013 | 1.634B |
| December 31, 2012 | 1.724B |
| September 30, 2012 | 1.725B |
| June 30, 2012 | 1.619B |
| March 31, 2012 | 1.478B |
| December 31, 2011 | 1.430B |
Free Cash Flow Range, Past 5 Years
3.702B
Minimum
Mar 2020
8.132B
Maximum
Jun 2021
6.089B
Average
6.441B
Median
Free Cash Flow Benchmarks
| Fonar Corp | 12.72M |
| XWELL Inc | -15.15M |
| ProPhase Labs Inc | -20.52M |
| Applied DNA Sciences Inc | -11.06M |
| Veracyte Inc | 26.33M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.251B |
| Cash from Investing (Quarterly) | -2.03B |
| Cash from Financing (Quarterly) | -1.821B |
| Free Cash Flow Per Share (Quarterly) | 2.354 |
| Free Cash Flow to Equity (Quarterly) | 213.00M |
| Free Cash Flow to Firm (Quarterly) | 973.15M |
| Free Cash Flow Yield | 3.44% |